Furthermore, while the specific anti-tumor mechanism of IFN-γ in particular tumors remains incompletely understood, its capabilities to inhibit tumor angiogenesis and modulate the sensitivity of tumor cells have long been reported (89). This evidence concerns the gene IFNG and neoplasm.